DaVita (NYSE:DVA) Hits New 52-Week High at $166.04

Shares of DaVita Inc. (NYSE:DVA) reached a new 52-week high on Thursday . The company traded as high as $166.04 and last traded at $162.14, with a volume of 53347 shares changing hands. The stock had previously closed at $163.16.

Wall Street Analyst Weigh In

A number of research firms have weighed in on DVA. Truist Financial raised their price objective on DaVita from $150.00 to $165.00 and gave the stock a “hold” rating in a research note on Tuesday, August 20th. Bank of America raised their price objective on DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research note on Wednesday, August 7th. TD Cowen raised their price objective on DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a research note on Wednesday, July 24th. StockNews.com downgraded DaVita from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 8th. Finally, UBS Group lifted their target price on DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $157.00.

DaVita Price Performance

The firm has a market cap of $14.38 billion, a PE ratio of 18.64, a PEG ratio of 0.95 and a beta of 0.87. The firm has a fifty day simple moving average of $147.19 and a two-hundred day simple moving average of $140.85. The company has a debt-to-equity ratio of 9.94, a quick ratio of 1.12 and a current ratio of 1.16.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $2.59 earnings per share for the quarter, topping analysts’ consensus estimates of $2.47 by $0.12. DaVita had a net margin of 6.86% and a return on equity of 77.00%. The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.15 billion. During the same period in the prior year, the company posted $2.08 EPS. The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. Equities analysts predict that DaVita Inc. will post 9.99 EPS for the current fiscal year.

Insider Buying and Selling at DaVita

In other news, CEO Javier Rodriguez sold 50,000 shares of the company’s stock in a transaction on Monday, September 16th. The stock was sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the transaction, the chief executive officer now directly owns 837,835 shares of the company’s stock, valued at $138,284,666.75. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, CFO Joel Ackerman sold 64,029 shares of the business’s stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $155.06, for a total transaction of $9,928,336.74. Following the sale, the chief financial officer now owns 111,481 shares in the company, valued at $17,286,243.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Javier Rodriguez sold 50,000 shares of the company’s stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the transaction, the chief executive officer now owns 837,835 shares in the company, valued at approximately $138,284,666.75. The disclosure for this sale can be found here. In the last quarter, insiders have sold 173,482 shares of company stock valued at $27,387,069. Company insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On DaVita

Several hedge funds have recently made changes to their positions in the company. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of DaVita during the 2nd quarter worth approximately $2,314,000. Point72 Asia Singapore Pte. Ltd. raised its holdings in shares of DaVita by 60.2% during the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 1,498 shares of the company’s stock valued at $208,000 after acquiring an additional 563 shares during the last quarter. Point72 Asset Management L.P. acquired a new position in shares of DaVita during the second quarter valued at approximately $9,615,000. Chase Investment Counsel Corp acquired a new position in shares of DaVita during the second quarter valued at approximately $2,933,000. Finally, B. Riley Wealth Advisors Inc. raised its holdings in shares of DaVita by 78.9% during the second quarter. B. Riley Wealth Advisors Inc. now owns 4,130 shares of the company’s stock valued at $572,000 after acquiring an additional 1,822 shares during the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.